AMD Advanced Micro Devices Inc.

AMD Introduces World’s Largest FPGA-Based Adaptive SoC for Emulation and Prototyping

AMD Introduces World’s Largest FPGA-Based Adaptive SoC for Emulation and Prototyping

AMD Versal Premium VP1902 adaptive SoC offers 2X the capacity of previous-generation FPGAs, providing chipmakers with the tools to bring new ASIC and SoC designs to market faster

Collaboration with EDA leaders Cadence, Siemens and Synopsys helps ensure chip designers have access to scalable ecosystem of fully-featured solutions

SANTA CLARA, Calif., June 27, 2023 (GLOBE NEWSWIRE) --  (NASDAQ: AMD) today announced the adaptive system-on-chip (SoC), the world’s largest1 adaptive SoC. The VP1902 adaptive SoC is an emulation-class, chiplet-based device designed to streamline the verification of increasingly complex semiconductor designs. Offering 2X2 the capacity over the prior generation, designers can confidently innovate and validate application-specific integrated circuits (ASICs) and SoC designs to help bring next generation technologies to market faster.

AI workloads are driving increased complexity in chipmaking, requiring next-generation solutions to develop the chips of tomorrow. FPGA-based emulation and prototyping provides the highest level of performance, allowing faster silicon verification and enabling developers to shift left in the design cycle and begin software development well before silicon tape-out. AMD, through Xilinx, brings over 17 years of leadership and six generations of the industry’s highest capacity emulation devices, which have nearly doubled in capacity each generation3.

“Delivering foundational compute technology to enable our customers is a top priority. In emulation and prototyping, that means delivering the highest capacity and performance possible,” said Kirk Saban, corporate vice president, Product, Software, & Solutions Marketing, Adaptive and Embedded Computing Group, AMD. “Chip designers can confidently emulate and prototype next-generation products using our VP1902 adaptive SoC, accelerating tomorrow’s innovations in AI, autonomous vehicles, Industry 5.0 and other emerging technologies.”

Confidently Emulate and Prototype Next-Generation Designs

As complexity grows in ASIC and SoC designs, especially with the rapid advancement of AI and ML-based chips, extensive verification of both silicon and software before tape-out is a must.

The VP1902 delivers industry leading capacity and connectivity, delivering 18.5M logic cells for 2X2 higher programmable logic density and 2X4 aggregate I/O bandwidth compared to the previous generation Virtex™ UltraScale+™ VU19P FPGA.

Iterate Designs Fast with Unmatched Debug Capabilities

Debug is essential for pre-silicon verification and concurrent software development. Finding and addressing bugs before tape-out keeps programs on schedule and budget. The VP1902 adaptive SoC leverages the Versal architecture, including the programmable network-on-chip, to provide up to 8X5 faster debugging compared to the prior generation VU19P FPGA.

Development Tools and Ecosystem Collaborations

The design suite provides customers with a comprehensive development platform to quickly design, debug and validate next-generation applications and technologies and accelerate time to market. New features that support more efficient development on the VP1902 adaptive SoC include automated design closure assistance, interactive design tuning, remote multi-user real-time debugging, and enhanced back-end compilation, which enables end users to iterate IC designs faster. 

AMD collaborates closely with the EDA community to help customers turn their innovations and technology vision into reality. Working closely with the top EDA vendors, including Cadence, Siemens and Synopsys helps designers access an ecosystem of fully-featured and scalable solutions.

The AMD Versal Premium VP1902 adaptive SoC will begin sampling in Q3 to early access customers with production expected in the first half of 2024.

Supporting Resources

  • Learn more about the
  • Follow AMD on 
  • Connect with AMD on

About AMD

For more than 50 years AMD has driven innovation in high-performance computing, graphics, and visualization technologies. Billions of people, leading Fortune 500 businesses, and cutting-edge scientific research institutions around the world rely on AMD technology daily to improve how they live, work, and play. AMD employees are focused on building leadership high-performance and adaptive products that push the boundaries of what is possible. For more information about how AMD is enabling today and inspiring tomorrow, visit the AMD (NASDAQ: AMD) , , , and  pages.

AMD, the AMD Arrow logo, Vivado, Versal, Virtex, UltraScale+ and combinations thereof are trademarks of Advanced Micro Devices, Inc. Other names are for informational purposes only and may be trademarks of their respective owners.

1 Based on AMD internal analysis in May 2023 with a 6-input LUT count to compare the Versal Premium VP1902 device versus the Intel Stratix 10 GX 10M FPGA. (VER-002)

2 Based on AMD internal analysis in May 2023, comparing the number of system logic cells of the Versal Premium VP1902 device versus the Virtex UltraScale+ VU19P device. (VER-001)

3 Based on AMD internal analysis in June 2023, comparing the number of system logic cells of the Versal Premium VP1902 device versus the Virtex 5 LX330T device and calculating an average across six generations. (VER-010)

4 Based on AMD Labs testing using an A6865 package to simulate the XPIO data rate performance of an AMD Versal Premium VP1902 device versus the published data rate of an AMD Virtex UltraScale+ VU19P FPGA. Actual results will vary. (VER-003)

5 Based on AMD internal analysis in May 2023, comparing the readback/writeback performance of an AMD Versal adaptive SoC CFI interface versus an AMD Virtex UltraScale+ FPGA ICAP interface. Actual performance will vary. (VER-004)

Contact:

Mike Sanchez

 AMD Communications

(209) 262-7458

Suresh Bhaskaran

 AMD Investor Relations

(408) 749-2845





EN
27/06/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Advanced Micro Devices Inc.

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TSLA TESLA INC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
WELL WELLTOWER INC.
GME GAMESTOP CORP. CLASS A
GERN GERON CORP.
FB FACEBOOK INC. CLASS A
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
CDR CD PROJEKT S.A.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
EA ELECTRONIC ARTS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
VTR VENTAS INC.
ISR ISORAY
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
DELL DELL TECHNOLOGIES INC CLASS C
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
SMCI SUPER MICRO COMPUTER
IDYA INC.
PASG IDEAYA BIOSCIENCES
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
KROS ADICET BIO INC
ITOS KEROS THERAPEUTICS
ZNTL ITEOS THERAPEUTICS
LRMR ZENTALIS PHARMACEUTICALS
PRAX LARIMAR THERAPEUTICS INC
U PRAXIS PRECISION MEDICINES
TVTX UNITY SOFTWARE
VRDN TRAVERE THERAPEUTICS INC
DAWN VIRIDIAN THERAPEUTICS INC
ELEV DAY ONE BIOPHARMACEUTICALS INC
MRVL ELEVATION ONCOLOGY
STX MARVELL TECHNOLOGY INC
APP SEAGATE TECHNOLOGY HLDGS PLC
ATXS APPLOVIN CORP
GFS ASTRIA THERAPEUTICS INC
GMTX GLOBALFOUNDRIES INC
VIGL GEMINI THERAPEUTICS INC
TYRA VIGIL NEUROSCIENCE INC
EWTX TYRA BIOSCIENCES INC
DDI EDGEWISE THERAPEUTICS INC
APGE DOUBLEDOWN INTERACTIVE CO LTD
SKLZ APOGEE THERAPEUTICS INC
EMBRAC B SKILLZ INC
MXL-US EMBRACER GROUP AB
MAXLINEAR
INC.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch